Security key
76200L309
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,211,492
- Total 13F value
- $31,558,000
- Share change
- -265,534
- SEC-reported price per share
- $14.27
- Number of holders
- 11
- Value change
- -$1,377,636
- Number of buys
- 6
- Number of sells
- 6
- Shares outstanding
- 96,946,691
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
11
Top holders
10
RZLT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Rezolute, Inc. SEC filings
Rezolute, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76200L309
Recent filing periods:
Ownership snapshot
Top reported holders of RZLT - Rezolute, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Genexine Inc.
Disclosed value leader
Genexine Inc.
Comparable rows
0/11
Latest evidence
31 Mar 2021
3/4/5
13F
Highest disclosed value: $173,462,643
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
Genexine Inc. has the largest disclosed position value at $173.46M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Genexine Inc.'s linked filing trail.
Disclosed position value
Top 5
Genexine Inc.
$173.46M
FEDERATED HERMES, INC.
$8.56M
CAXTON CORP
$3M
CITADEL ADVISORS LLC
$2.2M
ARMISTICE CAPITAL, LLC
$2.03M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Genexine Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$173,462,643
91,300,933 shares
|
— | 26 Apr 2019 |
| FEDERATED HERMES, INC. |
13F
Company
|
—
denominator unverified
|
$8,558,000
1,212,122 shares
|
— | 31 Mar 2021 |
| CAXTON CORP |
13F
Company
|
—
denominator unverified
|
$2,995,000
424,243 shares
|
— | 31 Mar 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$2,205,000
312,336 shares
|
— | 31 Mar 2021 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$2,033,000
288,000 shares
|
— | 31 Mar 2021 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$1,347,000
190,815 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
2,211,492
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
10
Q2 2021 holders
11
Holder diff
1
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend